Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walgreens Boots Alliance Inc.

http://www.walgreensbootsalliance.com

Latest From Walgreens Boots Alliance Inc.

Walgreens And CVS Agree To Opioid Settlements, But States Waiting To See Details

As states weigh their options, the history of past settlements will be a factor. One state signed onto the settlement with the distributors but opted out of the deal with J&J, netting it millions more, and with faster payment, than it would have received under the national settlement.

Legal Issues Advertising, Marketing & Sales

Trials In Focus: Walmart Joins Growing List Of Retailers Entering Clinical Research

SIGA provides an update on its monkeypox program, while Massive Bio announces progress on its AI platform for connecting cancer patients to trials, with additional updates from BridgeBio, the Oncology Institute, and CROs Caidya, Charles River Labs, Syneos Health and PPD parent Thermo Fisher Scientific.

Clinical Trials Companies

Opioid Jury Verdict May Change Settlement Equation For Sponsors

New York jury finds that Teva and distributor Anda violated state’s public nuisance law in their marketing and distribution of opioids. Such claims had been rejected by two previous courts and the verdict in this case shows the challenges companies face in ongoing litigation.

Advertising, Marketing & Sales Legal Issues

US FDA Cast As Culpable Player In Opioid Epidemic In Hulu’s Dopesick Series

Show depicts former agency officials approving OxyContin labeling that enabled Purdue to market it as nonaddictive and subsequently refusing pleas to restrict its use.

FDA Advertising, Marketing & Sales
See All

Company Information

  • Industry
  • Distributors
  • Diversified
  • Services
UsernamePublicRestriction

Register